CATALANO, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 10.266
EU - Europa 802
AS - Asia 357
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 11.431
Nazione #
US - Stati Uniti d'America 10.265
DE - Germania 258
CN - Cina 148
SG - Singapore 146
UA - Ucraina 136
IE - Irlanda 112
IT - Italia 101
GB - Regno Unito 50
KR - Corea 41
FR - Francia 33
FI - Finlandia 31
RU - Federazione Russa 31
SE - Svezia 20
BE - Belgio 13
JP - Giappone 7
PL - Polonia 6
VN - Vietnam 5
CH - Svizzera 4
IN - India 4
A2 - ???statistics.table.value.countryCode.A2??? 2
EU - Europa 2
GR - Grecia 2
HK - Hong Kong 2
UZ - Uzbekistan 2
AT - Austria 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
IR - Iran 1
NL - Olanda 1
RO - Romania 1
TR - Turchia 1
Totale 11.431
Città #
Woodbridge 3.204
Wilmington 2.704
Houston 2.470
Fairfield 274
Ann Arbor 234
Chandler 206
Ashburn 154
Seattle 129
Singapore 129
Jacksonville 126
Cambridge 100
Dublin 99
Medford 76
Dearborn 61
New York 56
Zhengzhou 49
Beijing 45
Santa Clara 45
Rome 43
Lawrence 36
San Diego 21
Menlo Park 17
Mülheim 17
Milan 13
Brussels 12
Moscow 12
Shanghai 10
Norwalk 9
London 8
Nürnberg 8
Falls Church 7
Mountain View 7
Hefei 6
University Park 6
Colorado Springs 5
Kunming 5
Boardman 4
Chicago 4
La Veta 4
Nanchang 4
Nuremberg 4
Phoenix 4
Redwood City 4
Verona 4
Brescia 3
Creede 3
Dong Ket 3
Kraków 3
Nanjing 3
Seoul 3
Wenzhou 3
Austin 2
Aversa 2
Chengdu 2
Del Norte 2
Hanoi 2
Hebei 2
Helsinki 2
Hong Kong 2
Jinan 2
Los Angeles 2
Munich 2
Palo Alto 2
Paris 2
Perugia 2
Pune 2
Sacramento 2
Saint Petersburg 2
San Mateo 2
San Venanzo 2
Simi Valley 2
Trieste 2
Xian 2
Yamazaki 2
Athens 1
Berlin 1
Billings 1
Brno 1
Budapest 1
Chiswick 1
Corona 1
Council Bluffs 1
Fuzhou 1
Guangzhou 1
Hounslow 1
Indiana 1
Kilburn 1
Kyoto 1
Lanzhou 1
Lappeenranta 1
Lausanne 1
Leawood 1
Malmo 1
Montagnola 1
Piraeus 1
Putian 1
Qingdao 1
Rzeszów 1
Salt Lake City 1
San Francisco 1
Totale 10.528
Nome #
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 459
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 452
A case of SRSF2 mutation in chronic lymphocytic leukemia 442
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity 420
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A New Class of Agents with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Who Were Imatinib-Resistant. 406
Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms 406
Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant 391
Benzodiazepine derivatives and uses thereof in medical field 388
null 385
Expression cDNA cloning of a novel oncogene with sequence similarity to regulators of small GTP-binding proteins 383
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 383
Imatinib-mesylate for all patients with hypereosinophilic syndrome? 382
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 381
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients 381
High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro 374
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant 373
“Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) induce apoptosis in primari chronic myelogenous leukemic cells”. 362
PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells. 361
Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors 356
Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant 350
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia 350
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 350
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 348
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 342
PML/RARA inhibits expression of HSP90 and its target AKT 321
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 311
Sarcoma di Kaposi e neoplasie linfoproliferative 301
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 300
[Current aspects of treatment of multiple myeloma] 282
PML/RARa interferes with NRF2 transcriptional activity increasing the sensitivity to ascorbate of acute promyelocytic leukemia cells 195
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies 176
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration 90
NPM1 mutated, BCR-ABL1 positive myeloid neoplasms: review of the literature 67
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment 54
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation. 51
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients 42
Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. 35
PLZF-RARΑ ENHANCES METABOLIC PLASTICITY AND ROS SCAVENGING IN AML CELLS 23
The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature 14
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes 12
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes 9
Totale 11.508
Categoria #
all - tutte 21.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.435 0 0 186 249 254 306 276 261 222 279 185 217
2020/20211.857 183 209 178 233 222 236 245 172 51 43 69 16
2021/2022370 15 55 8 25 11 24 26 13 22 25 24 122
2022/2023513 53 46 25 49 50 111 39 24 57 13 28 18
2023/2024202 29 7 17 8 25 65 3 1 3 5 6 33
2024/2025262 18 243 1 0 0 0 0 0 0 0 0 0
Totale 11.508